Drug Prevention of Reperfusion Lesions during Thrombolytic Therapy for Myocardial Infarction
Objective: to evaluate the efficacy of mexicor used to protect cardiac metabolism in patients with myocardial infarction during thrombolytic therapy with streptokinase. Subjects and methods. Fifty-four patients (mean age 51.2±5.5 years) with myocardial infarction, who underwent thrombolytic therapy...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
2010-02-01
|
Series: | Общая реаниматология |
Online Access: | https://www.reanimatology.com/rmt/article/view/508 |